Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
Indian Journal of Pathology and Microbiology · 2024
DOI: 10.4103/ijpm.ijpm_514_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2024. Verfasst von Ali Koyuncuer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Repressor Proteins, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Introduction
Well-differentiated neuroendocrine tumors of the appendix (A-WDNET) are the most common neoplasms of the appendix but are rare and incidental. INSM1 is a novel transcription factor marker with high sensitivity and specificity for neuroendocrine differentiation. It may display architecturally diverse tumor growth patterns including solid, nest, insular trabecular, and acinar.
Aims
The aim of this study was to determine the staining expression of INSM1 in A-WDNETs and detail the morphological tumor growth patterns. Materials and Methods: INSM1 immunohistochemistry was performed on 35 A-WDNET patients. Tumors were histologically classified according to their growth patterns.
Results
Thirty-five patients, 60% of whom were male, had a mean age of 30 years at diagnosis and a mean tumor size of 0.9 cm. Eight percent of the tumors invaded the mucosa/submucosa, 34.3% showed invasion into the muscularis propria, 57.1% showed invasion into the subserosa or mesoappendix, LN metastasis was observed in two patients, lymph-vascular invasion in two patients, and perineural invasion in five patients. Ninety-four percent of the tumors were grade 1, the mitotic rate was >2% in two cases, and Ki-67 PI was >3% in two cases. INSM1 was positive in all cases (100%), 1+ 8.6%, 2+ 5.7%, 3+ 17.1%, 4+ 68.6%, weak staining in 11.4%, moderate staining in 22.9%, and strong staining in 67.7%. Type A histological growth pattern was observed in 54.3%, type B in 31.4%, and type C in 14.3% architecturally.
Conclusions
INSM1 was positive in all A-WDNET morphological patterns and was 100% sensitive. INSM1 IHC can be used as an alternative to traditional neuroendocrine markers or in combination with the diagnosis of neuroendocrine tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
- Department of General Surgery, Health Sciences University Umraniye Training and Research Hospital, İstanbul, Turkey.
Zitieren
APA
Koyuncuer, A., Canbak, T., Acar, A., & Şahin, O. (2024). Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_514_23
Vancouver
Koyuncuer A, Canbak T, Acar A, Şahin O. Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience. Indian Journal of Pathology and Microbiology. 2024. doi:10.4103/ijpm.ijpm_514_23
BibTeX
@article{Koyuncuer2024,
author = {Koyuncuer, Ali and Canbak, Tolga and Acar, Aylin and Şahin, Onur},
title = {Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience},
journal = {Indian Journal of Pathology and Microbiology},
year = {2024},
doi = {10.4103/ijpm.ijpm_514_23}
}
EUVIMED